{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:18:47Z","timestamp":1790662727158,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AI070538"],"award-info":[{"award-number":["AI070538"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AI078304"],"award-info":[{"award-number":["AI078304"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["Al105789"],"award-info":[{"award-number":["Al105789"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"King Abdullah International Medical Research Center (KAIMRC)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jconrel.2013.10.032","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T15:10:11Z","timestamp":1383318611000},"page":"148-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":178,"special_numbering":"C","title":["Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles"],"prefix":"10.1016","volume":"173","author":[{"given":"Xinran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz M.","family":"Aldayel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2013.10.032_bb0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1389-0344(01)00101-0","article-title":"Recent developments in adjuvants for vaccines against infectious diseases","volume":"18","author":"O'Hagan","year":"2001","journal-title":"Biomol. Eng."},{"key":"10.1016\/j.jconrel.2013.10.032_bb0010","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.vaccine.2006.09.039","article-title":"Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants","volume":"25","author":"Romero Mendez","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1586\/14760584.6.5.685","article-title":"Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation","volume":"6","author":"Hem","year":"2007","journal-title":"Expert Rev. Vaccine"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0020","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1016\/j.vaccine.2007.06.049","article-title":"Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response","volume":"25","author":"Hansen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0025","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.vaccine.2004.10.014","article-title":"Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants","volume":"23","author":"Berthold","year":"2005","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.jconrel.2013.10.032_bb0030","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0264-410X(02)00169-X","article-title":"Mechanisms of stimulation of the immune response by aluminum adjuvants","volume":"20","author":"HogenEsch","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0035","doi-asserted-by":"crossref","first-page":"13406","DOI":"10.1074\/jbc.M500687200","article-title":"Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens","volume":"280","author":"Jones","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2013.10.032_bb0040","first-page":"143","article-title":"Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation","volume":"61","author":"Mannhalter","year":"1985","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jconrel.2013.10.032_bb0045","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/IAI.69.2.1151-1159.2001","article-title":"The common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism","volume":"69","author":"Ulanova","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2013.10.032_bb0050","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","article-title":"Aluminum compounds as vaccine adjuvants","volume":"32","author":"Gupta","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2013.10.032_bb0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0264-410X(02)00435-8","article-title":"Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres","volume":"21","author":"Gutierro","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymeth.2006.05.018","article-title":"Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity","volume":"40","author":"Kalkanidis","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4161\/hv.4.1.4886","article-title":"A comparison of anionic nanoparticles and microparticles as vaccine delivery systems","volume":"4","author":"Wendorf","year":"2008","journal-title":"Hum. Vaccine"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0075","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.4049\/jimmunol.173.5.3148","article-title":"Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors","volume":"173","author":"Fifis","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2013.10.032_bb0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejpb.2010.12.017","article-title":"Relationship between the size of nanoparticles and their adjuvant activity: data from a study with an improved experimental design","volume":"78","author":"Li","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2013.10.032_bb0085","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.4049\/jimmunol.174.12.7516","article-title":"Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor","volume":"174","author":"Lugade","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2013.10.032_bb0090","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.4049\/jimmunol.158.6.2723","article-title":"Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules","volume":"158","author":"Shen","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2013.10.032_bb0095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2009.08.023","article-title":"Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles","volume":"141","author":"Sloat","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0100","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1002\/app.27861","article-title":"Study of different effects on foaming process of biodegradable PLA\/starch composites in supercritical\/compressed carbon dioxide","volume":"109","author":"Hao","year":"2008","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.jconrel.2013.10.032_bb0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0110","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2013.10.032_bb0115","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1111\/j.1751-553X.2009.01139.x","article-title":"Fresh-frozen, optimal cutting temperature (OCT) compound-embedded bone marrow aspirates: a reliable resource for morphological, immunohistochemical and molecular examinations","volume":"32","author":"Lim","year":"2010","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.jconrel.2013.10.032_bb0120","series-title":"Chemistry of the Solid\u2013Water Interface: Processes at the Mineral\u2013Water and Particle\u2013Water Interface in Natural Systems","author":"Stumm","year":"1992"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0125","series-title":"Characterization of Porous Solids and Powders: Surface Area, Pore Size, and Density","author":"Lowell","year":"2004"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0130","article-title":"Multi-modal Superparamagnetic Nanoprobe: Harnessing Magnetic, Nuclear, and Optical Power for Diagnostic Imaging Applications","volume":"3","author":"Bumb","year":"2010"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1081\/PDT-120017526","article-title":"Effect of the degree of phosphate substitution in aluminum hydroxide adjuvant on the adsorption of phosphorylated proteins","volume":"8","author":"Iyer","year":"2003","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2013.10.032_bb0140","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nm0795-649","article-title":"Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity","volume":"1","author":"Falo","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2013.10.032_bb0145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0150","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1211\/jpp.58.4.0003","article-title":"Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice","volume":"58","author":"Sloat","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2013.10.032_bb0155","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.160.2.870","article-title":"CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen","volume":"160","author":"Davis","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2013.10.032_bb0160","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.vaccine.2004.07.050","article-title":"Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro","volume":"23","author":"Morefield","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0165","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1016\/j.biomaterials.2007.08.015","article-title":"Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response","volume":"28","author":"Kanchan","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymeth.2006.05.016","article-title":"Pathogen recognition and development of particulate vaccines: does size matter?","volume":"40","author":"Xiang","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0175","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0264-410X(93)90377-A","article-title":"Studies on the toxicities of aluminium hydroxide and calcium phosphate as immunological adjuvants for vaccines","volume":"11","author":"Goto","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2013.10.032_bb0180","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0264-410X(97)00054-6","article-title":"Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties","volume":"15","author":"Goto","year":"1997","journal-title":"Vaccine"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591300881X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591300881X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T19:17:38Z","timestamp":1688584658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836591300881X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":36,"alternative-id":["S016836591300881X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.10.032","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}